Sign in
CompletedNo phase

PENG Block forTranscatheter Aortic Valve Implantation

Key facts

Who runs it
Medipol University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
40 people enrolled
Started
10 Jun 2023
Ended
7 Dec 2023
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Postoperative analgesia management
  • PENG-Bupivacaine
  • Local infiltration-Bupivacaine
Record updated
20 November 2025

Who can take part

Age
20 years to 95 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • Patients with ASA classification I-III,
  • Aged 20-80 years
  • Who will be scheduled for TAVI

Who cannot take part

  • Take anticoagulant therapy,
  • Patients who have a history of bleeding diathesis,
  • History of chronic pain before surgery,
  • Who cannot assess their pain (dementia),
  • Who have an infection in the area and do not accept the procedure
  • Multiple trauma,
  • Who have been operated under spinal or epidural anesthesia,

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Pericapsular nerve group (PENG block) is a new fascial block defined by Arango et al. This block aims to block the femoral nerve and the accessory obturator nerve by injecting local anesthetic between the pubic ramus and psoas tendon. By blocking these nerves, anterior hip analgesia is created. It is a safe and effective method as it is applied superficially and under ultrasound guidance. In radiological and cadaver studies, it has been reported that when high volume is applied, total hip analgesia can be achieved by blocking the lateral femoral cutaneous, genitofemoral, obturator, and femoral nerves.

The 2 groups in the trial

  • Group PENG = PENG blockExisting treatment, for comparison

    PENG block will be performed

    Treatment: Postoperative analgesia management and PENG-Bupivacaine

  • Group C = Control groupOther group

    Local infiltration will be applied.

    Treatment: Postoperative analgesia management and Local infiltration-Bupivacaine

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of the Effect of Ultrasound-guided PENG Block on Postoperative Analgesia Management in Patients Undergoing Transcatheter Aortic Valve Implantation: A Randomized, Prospective Study
Publications
Record updated
20 November 2025